The haplotype harboring the SPINK1 c.101A>G (p.Asn34Ser) variant (also known as rs17107315:T>C) represents the most important heritable risk factor for idiopathic chronic pancreatitis identified to date. The causal variant contained within this risk haplotype has however remained stubbornly elusive. Herein, we set out to resolve this enigma by employing a hypothesis-driven approach. First, we searched for variants in strong linkage disequilibrium (LD) with rs17107315:T>C using HaploReg v4.1. Second, we identified two candidate SNPs by visual inspection of sequences spanning all 25 SNPs found to be in LD with rs17107315:T>C, guided by prior knowledge of pancreas-specific transcription factors and their cognate binding sites.
INTRODUCTION
Chronic pancreatitis is an inflammatory disease of the pancreas that leads to irreversible structural and functional damage to the pancreas (Majumder & Chari, 2016) . Analysis of four genes highly expressed in the pancreatic acinar cells ̶ PRSS1 (encoding cationic trypsinogen; MIM# 276000), PRSS2 (encoding anionic trypsinogen; MIM# 601564), SPINK1 (encoding pancreatic secretory trypsin inhibitor; MIM# 167790), and CTRC (encoding chymotrypsin C; MIM# 601405), which specifically degrades all human trypsinogen/trypsin isoforms (Szmola & Sahin-Tóth, 2007 )-has defined a trypsin-dependent pathway in the pathogenesis of chronic pancreatitis. Whereas gain-offunction missense and copy-number variants in PRSS1 (Le Maréchal et al., 2006; Whitcomb et al., 1996) and loss-of-function variants in SPINK1 (Witt et al., 2000) and CTRC (Masson, Chen, Scotet, Le Maréchal, & Férec, 2008; Rosendahl et al., 2008) predispose to chronic pancreatitis, loss-of-function variants in PRSS1 (Boulling et al., 2015; Chen, Le Maréchal, Lucas, Raguénès, & Férec, 2003; Whitcomb et al., 2012) and PRSS2 (Witt et al., 2006) protect against the disease.
The SPINK1 c.101A>G variant-associated haplotype (Witt et al., 2000) has emerged as the most important risk factor for idiopathic chronic pancreatitis (ICP) as a consequence of its relatively high prevalence worldwide (allele frequency, ∼ 0.7%) and its considerable effect size (odds ratio [OR] ≈ 14) (Aoun et al., 2008) . The SPINK1 c.101A>G variant, which was predicted to result in a p.Asn34Ser missense mutation, is termed rs17107315:T>C in the dbSNP database (https://www.ncbi.nlm.nih.gov/projects/SNP/). For the ease of reading, we shall describe this variant as rs17107315:T>C (c.101A>G) throughout the manuscript. The identification of the causal variant underlying this high-risk haplotype is of considerable biological interest, but it may also have significant diagnostic and therapeutic value. This notwithstanding, despite extensive studies, the underlying causal variant has remained stubbornly elusive (Chen & Férec, 2009 ). The earliest hypothesis, that p.Asn34Ser itself impairs the inhibitory action of SPINK1 on prematurely activated trypsin within the pancreas (Witt et al., 2000) , was not however supported by biochemical characterization of the wild-type and mutant enzymes expressed in three different systems, Saccharomyces cerevisiae BJ1991 strain (Kuwata et al., 2002) , Chinese hamster ovary cells (Boulling et al., 2007) , and human embryonic kidney 293T (HEK293T) cells (Király, Wartmann, & Sahin-Tóth, 2007) . A later hypothesis, that either rs17107315:T>C (c.101A>G) or one of the four intronic variants in linkage disequilibrium (LD) with it might affect pre-mRNA splicing (Chen et al., 2001) , also failed to garner any evidential support, either from reverse-transcription PCR (RT-PCR) analysis of total RNA prepared from pancreatic tissues of rs17107315:T>C (c.101A>G) homozygotes (Masamune et al., 2007) or from experiments performed in the context of both mini-gene (Kereszturi, Kiraly, & Sahin-Toth, 2009 ) and full-gene (Boulling, Chen, Callebaut, & Férec, 2012) systems. An alternative hypothesis, that the causal variant resides within an uncharacterized flanking region of the SPINK1 gene with regulatory potential (Kereszturi et al., 2009 ) was explored in the present study.
MATERIAL AND METHODS

Study subjects
The 548 French ICP patients and 562 controls have been previously reported (Field et al., 2015; Witt et al., 2013) . Most of the 1,104 Han Chinese ICP patients and 1,196 healthy controls have been described in a recent publication (Zou et al., 2016) . The Indian chronic pancreatitis patients (n = 347) and controls (n = 264) included in this study have been described previously (Paliwal et al., 2013) . Informed consent was obtained from each patient, and the study was approved by the respective ethics committees of Brest University, the Changhai Hospital, and the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) in Hyderabad.
Reference sequences
The SPINK1 genomic sequence was obtained from human GRCh37/hg19 (https://genome.ucsc.edu/). GenBank accession number NM_003122.4 was used as the SPINK1 cDNA reference sequence.
Search for variants in strong LD with the rs17107315:T>C (c.101A>G) variant
This was performed with HaploReg v4.1 (http://www.broadinstitute. org/mammals/haploreg/haploreg.php) (Ward & Kellis, 2016) , using an LD threshold of r² ≥ 0.40 and querying the 1000 Genomes Project (1000GP) Phase 1 data (http://www.1000genomes.org/category/ phase-1/) in the context of the European population.
Verification and search for HNF1A-binding sites
The search for HNF1A-binding sites was performed using RSAT (http://www.rsat.eu/) (Medina-Rivera et al., 2015) under default conditions, with Homo sapiens GRCh37/hg19 being used as the organismspecific background.
HNF1A−PTF1L cis-regulatory module prediction
We performed a comprehensive review of the literature and collated 10 experimentally validated PTF1L-binding sites within the promoters of human, rat, or mouse genes that are known to be highly expressed in the pancreatic acinar cells (Beres et al., 2006; Boulling et al., 2011; Holmstrom et al., 2011) . Each of these PTF1L-binding sites comprised a 5' E-Box (length = 6) and a 3' TC-Box (length = 7), separated by a 4-or 5-nucleotide spacer sequence (Beres et al., 2006; Boulling et al., 2011) .
We first aligned the 10 E-Box and 10 TC-Box sequences separately to create two distinct position frequency matrices (PFMs) by counting the occurrences of each nucleotide at each position. Then, to construct appropriate PFMs for the PTF1L-binding site, we separated the E-Box and TC-Box PFMs by four or five nonspecific nucleotides to create two PTF1L PFMs, termed PTF1_4N and PTF1_5N, respectively. The nucleotide frequency within the spacer was adjusted to correspond to nucleotide frequencies in the human genome at large (A: 0.255, T: 0.267, G: 0.242, C: 0.236). Sequence logos for the two PTF1L PFMs were created with WebLogo (http://weblogo.berkeley.edu/) (Crooks, Hon, Chandonia, & Brenner, 2004) .
The above-generated PTF1L PFMs and the JASPAR database (http://jaspar.genereg.net/)-provided HNF1A (MA0046.2) PFMs (Mathelier et al., 2016) were then used to calculate their respective position weight matrices (PWMs). This task was achieved with the freely online available RSAT matrix-scan (full options) tool (MedinaRivera et al., 2015) . PWMs were generated using default parameters with the exception of the "background model estimation method" that was set to "organism-specific: Homo sapiens GRCh37." Transcription factor-binding site (TFBS) prediction was performed using the "Individual Matches" mode with default scanning options. "P value upper threshold" was exceptionally increased to 10 −3 to calculate the matrix score for TFBS of weak relevance (i.e., mutated TFBSs). The SPINK1 locus plus ± 20 kb flanking sequences were analyzed for cis-regulatory module (CRM) prediction using the RSAT CRER scanning option under default conditions, except for the following parameters: lower CRER size = 1, upper CRER size = 200, site P value <10 −4 .
Assessment of phylogenetic conservation, chromatin accessibility, and histone marks in the chromosomal region of interest
Phylogenetic conservation data as represented by "Placental Mammal Conservation by PhastCons" and "Placental Mammal Conserved Elements" tracks (both using 46 mammal species) were directly taken from the UCSC Genome Browser (https://genome.ucsc.edu/) (Kent et al., 2002) . Accessible chromatin regions and histone marks in the pancreatic tissues of two donors were obtained from the Website of the NIH Roadmap Epigenomics Mapping Consortium (http://www.roadmapepigenomics.org/) (Bernstein et al., 2010) .
Search for SNPs affecting the expression of SPINK1 in the pancreas tissue
This analysis was performed using the GTEx dataset available at http://www.gtexportal.org/home/) (Carithers et al., 2015) .
Construction of luciferase promoter reporter plasmids
A fragment spanning −346 to +49 relative to the transcription start site (i.e., c.1-61 in accordance with Yasuda et al. [1998] with the A of the translational initiation codon ATG of the gene being designated as c.1) of the SPINK1 gene was first PCR amplified from a genomic DNA sample. PCR amplification was performed by means of the HotStarTaq Master Mix Kit (Qiagen, Courtaboeuf, France) with primers (Supp. Table S1) designed to be used with the In-Fusion R HD Cloning Kit (Clontech, Saint-Germain-en-Laye, France), as previously described (Boulling et al., 2015) . The resulting pGL3 reporter construct harboring the wild-type sequence of the human SPINK1 proximal promoter upstream of the firefly luciferase gene was termed hSPINK1pp.
The same strategy was used to insert a 330-bp DNA fragment containing HNF1A−PTF1L CRM5 into hSPINK1pp at a position downstream of the luciferase gene. This was achieved using the primers described in Supp. Table S1 , after plasmid digestion with BamHI. This latter construct was termed hSPINK1pp+E. All SPINK1 promoter and enhancer variants were then generated from their respective wildtype constructs by site-directed mutagenesis using the Quick Change
Site Directed Mutagenesis Kit (Stratagene, Massy, France). All resulting plasmids were checked by Sanger sequencing.
Construction of transcription factor expression plasmids
Human pancreas cDNAs were obtained from 1 g human pancreas total RNA (Amsbio, Abingdon, UK) by reverse transcription using the HNF1A genes, were termed pcDNA3.1-PTF1A, pcDNA3.1-RBPJL, and pcDNA3.1-HNF1A, respectively. The orientation and sequence of each insert were checked by sequencing. Plasmids were produced using the Nucleobond Xtra Midi EF Kit (Macherey-Nagel, Hoerdt, France).
Cell culture, quantitative RT-PCR analyses, cotransfection transactivation experiments, luciferase reporter gene assay, and electrophoretic mobility shift assay
These procedures are described in Supp. Methods.
Analysis of rs142703147:C>A and rs17107315:T>C (c.101A>G) in French, Chinese, and Indian subjects
The procedures for sequencing the two polymorphic sites are described in Supp. Methods. The LD between the two SNPs was calculated by means of CubeX (http://www.oege.org/software/cubex/) (Gaunt, Rodriguez, & Day, 2007) . To test for the effect of one SNP being conditional upon the other, a logistic regression model was used where the log (odds i ) of disease of each individual i was modeled as a linear function of the minor allele dosage g i,k at each SNP k (g i,k = 0, 1, or 2) and the additive effect of this minor allele ß k . An indicator variable i was added to the model to account for the geographic origin of the individuals. The full model (1) with the effects of the two SNPs was compared against each restricted model with ß 1 and ß 2 , respectively, set to zero to test for the effect of each SNP conditional upon the other:
The significance of the improvement in fit was tested by comparing the difference of deviances to a distribution with 1 degree of freedom.
The glm() function of R version 3.2.2 was used for fitting the model (R Core Team, 2015) . S1 ). Of the HaploReg v4.1-annotated motifs that were altered by these SNPs, only the HNF1A motif, impacted by rs17107287:C>T (Supp. Fig. S1 ), was deemed to be of potential functional interest owing to the known role of HNF1A in pancreatic exocrine physiology (Boulling et al., 2011; Molero et al., 2012) . However, we were unable to validate this prediction using RSAT under default conditions (MedinaRivera et al., 2015) .
RESULTS
Search for variants in strong LD
Identification of two SNPs that potentially disrupt a PTF1L-binding site by visual inspection
Assuming that the hypothesis that the causal variant resides within a flanking region of the SPINK1 gene (Kereszturi et al., 2009 ) was nevertheless correct, and that we had successfully identified all the SNPs in strong or perfect LD with rs17107315:T>C (c.101A>G) variant, the most probable reason for failing to confirm our prediction was deemed to be that a functionally relevant TFBS had been missed by the relevant search programs. We previously encountered just such a case during the functional characterization of SPINK1 promoter variants; an HNF1A-binding site was readily predicted by MATCH (http://www.gene-regulation.com/pub/programs.html#match), but a PTF1L-binding site was identified instead by visual inspection (Boulling et al., 2011) (Fig. 1A) . PTF1L is a pancreatic-specific trimeric complex comprising PTF1A, RBPJL, and one of the several ubiquitously expressed class A bHLH family members (Boulling et al., 2011; Holmstrom et al. 2011; Masui et al., 2008) . We therefore visually inspected the local DNA sequence spanning all the aforementioned 25 SNPs (Supp. Fig. S1 ) against the previously described canonical sequence of PTF1L TFBS, CACCTG….TTTCCC (Boulling et al., 2011) . We identified two SNPs, rs142703147:C>A (Fig. 1B) and rs192858015:G>A, to disrupt a putative PTF1L TFBS.
3.3 Using a putative HNF1A−PTF1L CRM to filter rs142703147:C>A and rs192858015:G>A There is increasing evidence that the spatial and temporal expression of genes is enabled by the coordinated action of multiple transcription factors through CRMs (Lelli, Slattery, & Mann, 2012) . Moreover, distal CRMs, also called enhancers, can often be predicted by sequence signatures extracted from proximal promoters (Taher, Smith, Kim, Ahituv, & Ovcharenko, 2013) . Given the important roles played by HNF1A and PTF1L in adult pancreatic acinar cells (Holmstrom et al., 2011; Masui et al., 2008; Molero et al., 2012) , it did not appear unreasonable to speculate that their closely spaced TFBSs within the SPINK1 proximal promoter (Fig. 1A ) could define such a CRM. We therefore screened the ±200 bp sequences flanking rs142703147:C>A and rs192858015:G>A by means of RSAT (Medina-Rivera et al., 2015) and identified a putative HNF1A TFBS only in the immediate vicinity of rs142703147:C>A (Fig. 1B) . In other words, of the two SNPs, CRMs in terms of both evolutionary conservation, chromatin accessibility, and histone marks (Shlyueva, Stampfel, & Stark, 2014) . To this end, we first built PFMs for the bipartite PTF1L motif, with the E-Box and TC-Box being separated by 4 bp and 5 bp, respectively ( Fig. 2A and   B ). We then converted the PTF1L PFMs and JASPAR-derived HNF1A
PFMs to their respective PWMs and scanned the SPINK1 locus plus ±20 kb flanking regions for putative HNF1A−PTF1L CRMs by means of RSAT (Medina-Rivera et al., 2015) . In addition to the HNF1A−PTF1L
CRM illustrated in Figure 1A (termed CRM4) and that illustrated in Figure 1B (termed CRM5), four additional putative CRMs were identified (i.e., CRMs 1, 2, 3, and 6; Fig. 1C ). It is pertinent to mention that two putative PTF1L-binding sites were also predicted immediately upstream of the HNF1A-binding site in the proximal promoter.
F I G U R E 1 Discovery of a candidate causal variant underlying the chronic pancreatitis-associated SPINK1 c.101A>G (rs17107315:T>C) variantcontaining haplotype. A: The HNF1A-and PTF1-L-binding sites previously identified within the SPINK1 proximal promoter (Boulling et al., 2011) . This motif signature corresponds to CRM4 illustrated in C. Note that (i) the nucleotide positions are in accordance with the A of the translational initiation codon ATG of the SPINK1 gene being designated as c.1; (ii) the sequence given is on the sense strand with respect to the reading frame of the SPINK1 gene; (iii) HNF1A and PTF1L were previously termed HNF1 and PTF1, respectively (Boulling et al., 2011) ; and (iv) the TC-Box of the PTF1L-binding site was previously annotated as comprising six nucleotides (Boulling et al., 2011) . Two chronic pancreatitis-predisposing variants that occurred within the HNF1A-binding site, c.147A>G and c.142T>C (Boulling et al., 2011) , are also shown. B: Illustration of the bipartite PTF1L TFBS disrupted by rs142703147C>A (c.-4141G>T) and the RSAT-predicted HNF1A TFBS. This panel represents an enlarged view of CRM5 illustrated in C. Nucleotide positions are in accordance with hg19, with the A of the translational initiation codon ATG of the SPINK1 gene being designated as c.1. It should be noted that the sequence is given on the antisense strand with respect to the reading frame of the SPINK1 gene. N 55 indicates 55 nucleotides whose sequence is not shown. C: Evaluation of the predicted putative PTF1L−HNF1A CRMs within the SPINK1 locus plus ± 20 kb flanking sequence in the context of phylogenetic conservation and accessible chromatin regions. PC and CE, placental mammal conservation by PhastCons and placental mammal conserved elements obtained from the UCSC Genome Browser. Accessible DNA regions in the pancreatic tissues of two donors, as determined by DNase-seq, were obtained from the Website of the NIH Roadmap Epigenomics Mapping Consortium. LD SNPs refer to all the SNPs (with the exception of the below described rs138251740A>G; see Supp. Fig. S1 ) that were found to be in strong or perfect LD with the rs17107315T>C (c.101A>G) variant (highlighted in green). Apart from rs17107315T>C (c.101A>G) and rs142703147C>A (c.-4141G>T), the other two SNPs that were specifically mentioned in the manuscript (i.e., rs17107287C>T and rs192858015G>A) are also clearly indicated. Note that the not shown rs138251740A>G (located further downstream of chr5:147,230,000) is located neither within a putative PTF1L−HNF1A CRM nor within a region showing strong evolutionary conservation and high chromatin accessibility However, these PTF1L-binding sites were excluded from further consideration because neither of them was located within an evolutionarily conserved region.
Of the six CRMs, only CRM4 and the rs142703147:C>A (c.- (Fig. 1C) .
Using data from the Website of the NIH Roadmap Epigenomics
Mapping Consortium, we did not find any strong histone 3 lysine 4 monomethylation (H3K4me1) or H3K27 acetylation (H3K27ac) marks across the SPINK1 locus plus ±20 kb flanking regions in the human pancreatic tissues of two healthy donors (Supp. Fig. S2 ). In addition, no
SNPs were found to affect the expression of SPINK1 in human pancreas in the GTEx database. Each of these PTF1L TFBSs comprised a 6-bp E-Box motif and a 7-bp TC-Box motif, separated by a 4-or 5-nucleotide spacer sequence (4N or 5N) .
The aligned E-Box and TC-Box sequences were used to generate two distinct PFMs. Nucleotides that are not perfectly conserved within the E-Box or TC-Box are highlighted in red. Luc., luciferase reporter gene assay. B: Sequence logos for the two sets of PTF1L PFMs, PTF1_4N, and PTF1_5N. They were generated by inserting a 4-or 5-nucleotide spacer sequence between the aforementioned E-Box and the TC-Box PFMs
Cotransfection transactivation experiments demonstrating functional synergy between the HNF1A and PTF1L transcription factors in regulating the promoter activity of the SPINK1 gene
The premise of the CRM concept is that multiple transcription factors cooperate in regulating gene expression through concomitant binding to their cognate binding sites in a gene's regulatory sequence.
We therefore tested the functional synergy between the HNF1A and PTF1L transcription factors in regulating the promoter activity of the SPINK1 gene by means of a cotransfection transactivation assay, which was performed essentially as previously described (Holmstrom et al., 2011) . To this end, we constructed a promoter-reporter vector wherein a CRM4-containing SPINK1 promoter sequence was cloned into the pGL3 basic vector upstream of the firefly luciferase gene (termed hSPINK1pp) and three pcDNA3.1 expression vectors containing the coding sequences of the PTF1A, RBPJL, and HNF1A genes, respectively. The cotransfection transactivation assay had to be performed in a cell line that lacked endogenous expression of these transcription factors; the nonpancreatic HEK293T cell line, which was confirmed to lack expression of the three transcription factor genes as well as the SPINK1 gene by quantitative RT-PCR analysis (Supp. Masui et al., 2008) . SPINK1 promoter reporter gene activity increased 1.8-fold and 1.3-fold upon expression of HNF1A alone and PTF1A + RBPJL alone, respectively, but increased 6.3-fold upon expression of all three (Fig. 3) . These observations were interpreted in terms of a synergistic effect between the HNF1A and PTF1-L transcription factors.
Two variants residing within the CRM4 HNF1A-binding site in the SPINK1 promoter have been reported to predispose to chronic pancreatitis (Fig. 1A) . Both variants were predicted to disrupt the HNF1A-binding site (Fig. 4A ). We tested their potential effects on the cooperative action between the HNF1A and PTF1L transcription factors and found that each resulted in the abolition of the aforementioned synergistic effect (Fig. 4B ). promoter element in a reporter gene assay (Shlyueva et al., 2014) .
We therefore inserted a fragment containing the HNF1A−PTF1L We also performed the above analysis in rat pancreatic acinar AR42J cells treated with dexamethasone. Under our experimental conditions, hSPINK1pp drove a mere 2.3-fold increased expression of the reporter gene as compared with the promoter-less pGL3 basic vector, and no significant differences were observed between the two alleles of rs142703147 in enhancing hSPINK1pp-driven reporter gene expression (Supp. Fig. S4A ). Analysis of the relative mRNA expression levels of the rat Prss1, Ctrc, Spink1, Ptf1a, Rbpj1, Hnf1a genes in the dexamethasone-differentiated AR42J cells indicated poor expression of both the Spink1 and Hnf1a genes (Supp. Fig. S4B ).
3.7 Electrophoretic mobility shift assay providing further supporting evidence for the functional effect of the rs142703147C>A (c.
-4141G>T) variant
We further performed electrophoretic mobility shift assay using nuclear extracts prepared from HEK293T cells transfected with the two expression plasmids encoding PTF1A and RBPJL genes. This assay demonstrated that rs142703147A disrupted the interaction between the PTF1L transcription factor and its cognate-binding site (Fig. 6 ). . Table S3 ) and 15.12 versus 14.82 in the Indian dataset (Supp . Table S4 ).
To test whether the two SNPs had an impact on disease risk, conditional analyses were performed. Nested logistic regression models were fitted, namely, M1, effect of SNP1 (rs142703147:C>A) + ethnicity; M2, effect of SNP2 (rs17107315:T>C) + ethnicity; and M3 (i.e., the full model), effect of SNP1 + effect of SNP2 + ethnicity. By comparing the likelihood of M2 versus M3, we tested for the effect of SNP1 conditional upon SNP2, obtaining a 2 value of 5.65 and a P value of 1.74 × 10 −2 . By comparing the likelihood of M1 versus M3, we tested for the effect of SNP2 conditional upon SNP1, obtaining a 2 value of 30.65
and a P value of 3.09 × 10 −8 . These results suggested that both SNPs exert an effect on disease risk.
DISCUSSION
The association of the rs17107315:T>C (c.101A>G)-containing haplotype with chronic pancreatitis was first described 17 years ago (Witt et al., 2000) . As opined by Kereszturi et al. (2009) , "The mechanism of action of the [SPINK1] p.Asn34Ser-associated haplotype remains one of the most intriguing, unsolved questions of pancreas genetics." These authors proposed that the causal variant was most probably located within an uncharacterized flanking region of the SPINK1 gene. However, distal regulatory variants are notoriously difficult to identify because the causal variant-harboring regulatory elements act independently of the distance and orientation to their target genes (Mathelier, Shi, & Wasserman, 2015; Shlyueva et al., 2014 Fig. 2 ).
Employing a novel CRM-based approach to filter the aforementioned two SNPs, we excluded one of them from further consideration.
The remaining single variant, rs142703147C>A (c.-4141T), is located approximately 4 kb from the SPINK1 promoter, consistent with the current consensus that enhancers tend to be located within 10 kb of their associated transcription start sites genome wide (MacIsaac et al., 2010; Taher et al., 2013) . The functionality of this variant was strongly supported by evolutionary conservation and chromatin accessibility data (Fig. 1C) . By contrast, based upon ChIP-seq data from the human pancreatic tissues of two donors, no strong enhancer-associated histone marks (i.e., H3K4me1 and H3K27ac) were noted in the vicinity of the rs142703147C>A (c.-4141T)-affected motif (Supp. Fig. S2 ).
However, it is known that (1) none of the known histone modifications correlate perfectly with enhancer activity and (2) there is no evidence that either H3K4me1 or H3K27ac is sufficient, necessary, or even mechanistically involved in transcription (Shlyueva et al., 2014) .
Additionally, in the publicly available GTEx dataset, no single SNP is known to influence SPINK1 expression in the pancreas. which have been previously used for analyzing PRSS1 (Boulling et al., 2015) and SPINK1 (Derikx, Geisz, Kereszturi, & Sahin-Tóth, 2015) promoter variants, may be relevant with respect to the current "gold standard" in vitro method for evaluating the effect of an enhancer element placed in the vicinity of a promoter element in a reporter gene assay (Shlyueva et al., 2014) . We therefore performed this analysis in AR42J cells treated with dexamethasone but did not obtain expected results (Supp. Fig. S4A ). This can essentially be accounted for by the poor expression of both the Spink1 and Hnf1a genes in the AR42J cells treated with dexamethasone (Supp. Fig. S4B ). Here, it is pertinent to note that in the current study, the inserted SPINK1 promoter drove a mere 2.3-fold increased expression of the reporter gene as compared with the promoter-less pGL3 basic vector (Supp. Fig. S4A ), whereas in a previous reporter gene assay, the corresponding increase for the inserted SPINK1 promoter was >15-fold . A variety of parameters affecting cell characteristics that pertain to cell culture conditions, including medium used, fetal bovine serum percentage and composition, cell confluence, number of cell passages at time of transfection, and protocol for dexamethasone treatment, could have significantly affected the experimental outcomes (Baker, 2016) . Additionally, the SPINK1 promoter sequence used for reporter gene assay differs between the current study and the previous study ; the inserted promoter segments correspond to c.1-407 to c.1-13 and c.1-541 to c.35 of the SPINK1 genomic sequence. Finally, we should add that we did not attempt to perform experiments in mouse-derived pancreatic acinar tumor 266-6 cells because these cells displayed no difference with HEK293T cells in terms of SPINK1 promoter-driven reporter gene expression .
Although we provide strong in silico and in vitro evidence that the rs142703147C>A (c.-4141T) variant is of functional significance, our findings from population genetic studies clearly suggest that it is only one component of the chronic pancreatitis-predisposing functional elements contained within the risk haplotype of interest. Thus, we are still far from obtaining a complete understanding of the pathogenic mechanism(s) underlying the most important heritable risk factor for idiopathic chronic pancreatitis identified to date (Witt et al., 2000) even after a 17-year interlude. Indeed, even though a cis variant located in the immediate vicinity of the gene under study would be a priority in terms of being tested, the true causative variant can be located at some distance from the haplotype associated with the phenotype (Smemo et al., 2014) . Further studies that aim to discover other variants contributing to the high-risk haplotype as well as to improve the characterization of the functional SNP identified here are warranted. In a more general context, our case serves to exemplify the difficulties that are frequently encountered in tracking down and unmasking the causal variants responsible for disease associations that reside within the extensive regulatory regions flanking our genes rather than within the gene coding regions themselves (Mathelier et al., 2015; Spielmann & Mundlos, 2016; Yao, Berman, & Farnham, 2015) . Nonetheless, the novel approach employed in this study will, we believe, help to stimulate the development of new strategies to identify the causal regulatory variants underlying many human-inherited disease associations.
